GSK drug’s new approval sets up competition with Dupixent

And more biotech news brought to you by The Readout.

Read the full article here

Related Articles

Open Doors

Open Doors ‘22 is a new civic collaboration that brings together the most creative minds working in health, medicine, and the life sciences.